معرفی
Timothy N.J. Bullock, Ph.D., is a Professor of Pathology at the University of Virginia. His research focuses on harnessing dendritic cells as immunotherapeutic vaccines against melanoma and other cancers, with significant emphasis on T cell activation mechanisms and co-stimulatory pathways.
- Education: Thomas Jefferson University, Philadelphia, PA
Research highlights include:
- Investigating synergy between MHC class I and II peptide vaccines
- Elucidating CD4+ T cell support for CD8+ T cell tumor infiltration
- Characterizing CD70-mediated co-stimulation in dendritic cell vaccines
- Studying metabolic regulation of dendritic cell function in tumors
- Developing peptide+adjuvant vaccines for melanoma and breast cancer patients
His work demonstrates how coordinated CD4+/CD8+ T cell responses and DC activation can overcome tumor immune evasion, with clinical applications in vaccine design.
Publications reveal consistent focus on:
- CD70-CD27 co-stimulatory axis
- Memory T cell dynamics
- PD-1 regulation in tumor microenvironment
- IL-7 receptor expression in memory formation
- Dendritic cell licensing mechanisms
- Translational cancer immunotherapy
۰مقاله ثبتشده
